Role of endothelin B receptor in oligodendroglioma proliferation and survival: In vitro and in vivo evidence

Molecular Medicine Reports

Volumn 9, Issue 1, 2014, Pages 229-234

  Wan, Xin ^a   Zhang, Longbo ^a   Jiang, Bing ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Endothelin; Endothelin B receptor; Extracellular signal regulated kinase; Intratumoral injection; Ki67; Oligodendroglioma; Orthotopic xenograft; Proliferation; Survival

Indexed keywords

ANIMALS; BUTADIENES; CELL LINE, TUMOR; CELL SURVIVAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; KAPLAN-MEIER ESTIMATE; KI-67 ANTIGEN; MICE; MICE, NUDE; NITRILES; OLIGODENDROGLIOMA; OLIGOPEPTIDES; PIPERIDINES; RECEPTOR, ENDOTHELIN B; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSPLANTATION, HETEROLOGOUS;

EID: 84893861606     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2013.1746     Document Type: Article

References (18)

1. Anguelova E, Beuvon F, Leonard N, et al.: Functional endothelin ET B receptors are selectively expressed in human oligodendrogliomas. Brain Res Mol Brain Res 137: 77-88, 2005.
2. Chen HL, Chew LJ, Packer RJ and Gallo V: Modulation of the Wnt/beta-catenin pathway in human oligodendroglioma cells by Sox17 regulates proliferation and differentiation. Cancer Lett 35: 361-371, 2013.
3. Ohgaki H and Kleihues P: Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. J Neuropathol Exp Neurol 64: 479-489, 2005.
4. Burton E and Prados M: New chemotherapy options for the treatment of malignant gliomas. Curr Opin Oncol 11: 157-161, 1999.
5. Nutt CL, Noble M, Chambers AF and Cairncross JG: Differential expression of drug resistance genes and chemosensitivity in glial cell lineages correlate with differential response of oligodendrogliomas and astrocytomas to chemotherapy. Cancer Res 60: 4812-4818, 2000.
6. Branle F, Lefranc F, Camby I, et al.: Evaluation of the efficiency of chemotherapy in in vivo orthotopic models of human glioma cells with and without 1p19q deletions and in C6 rat orthotopic allografts serving for the evaluation of surgery combined with chemotherapy. Cancer 95: 641-655, 2002.
7. Levin ER: Endothelins. New Engl J Med 333: 356-363, 1995.
8. Schinelli S: Pharmacology and physiopathology of the brain endothelin system: an overview. Curr Med Chem 13: 627-638, 2006.
9. Egidy G, Eberl LP, Valdenaire O, et al.: The endothelin system in human glioblastoma. Lab Invest 80: 1681-1689, 2000.
10. Paolillo M, Barbieri A, Zanassi P and Schinelli S: Expression of endothelins and their receptors in glioblastoma cell lines. J Neurooncol 79: 1-7, 2006.
11. Paolillo M, Russo MA, Curti D, Lanni C and Schinelli S: Endothelin B receptor antagonists block proliferation and induce apoptosis in glioma cells. Pharmacol Res 61: 306-315, 2010.
12. Mathieu V, De Nève N, Le Mercier M, et al.: Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia 10: 1383-1392, 2008.
13. Le Mercier M, Fortin S, Mathieu V, et al.: Galectin 1 proangiogenic and promigratory effects in the Hs683 oligodendroglioma model are partly mediated through the control of BEX2 expression. Neoplasia 11: 485-496, 2009.
14. Schilling H, Sehu KW and Lee WR: A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques. Invest Ophthalmol Vis Sci 38: 2081-2092, 1997.
15. Bagnato A, Loizidou M, Pflug BR, Curwen J and Growcott J: Role of the endothelin axis and its antagonists in the treatment of cancer. Br J Pharmacol 163: 220-233, 2011.
16. Grimshaw MJ, Hagemann T, Ayhan A, Gillett CE, Binder C and Balkwill FR: A role for endothelin-2 and its receptors in breast tumor cell invasion. Cancer Res 64: 2461-2468, 2004.
17. Tanese K, Fukuma M, Ishiko A and Sakamoto M: Endothelin-2 is upregulated in basal cell carcinoma under control of Hedgehog signaling pathway. Biochem Biophys Res Commun 391: 486-491, 2010.
18. Wiesmann F, Veeck J, Galm O, et al.: Frequent loss of endothelin-3 (EDN3) expression due to epigenetic inactivation in human breast cancer. Breast Cancer Res 11: R34, 2009.